Correlates of adherence with transdermal nicotine

Cooper, Theodore V.; DeBon, Margaret; Stockton, Michelle B.; Klesges, Robert C.; Steenbergh, Timothy A.; Sherrill-Mittleman, Deborah; Jennings, Lyndy C.; Johnson, Karen C.

doi:10.1016/j.addbeh.2004.02.033

Cited by 36 publications

(37 citation statements)

References 20 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Alterman et al (1999) found that only 55% of general smoking treatment participants used the patch as prescribed, and that at the group level, patch use was related to outcomes. Similarly, Cooper et al (2004) found that patch use was associated with better treatment participation and cessation outcomes, and that perfect adherence occurred in only one-third of participants. Likewise, adherence problems have been noted among HIV patients in other areas as well (Ingersoll 2004;Ingersoll and Heckman 2005).…”

Section: Discussionmentioning

confidence: 89%

A Test of Motivational Plus Nicotine Replacement Interventions for HIV Positive Smokers

2007

View full text Add to dashboard Cite

The purpose of this study was to test two combination motivational plus pharmacological interventions for smoking cessation among HIV positive smokers. Participants were 40 adults receiving HIV care who smoked daily reporting interest in smoking reduction. Measures were administered at baseline, 1-month, and 3-month follow-ups. Participants were randomly assigned to self-guided reading plus nicotine patch (n = 18) or motivational interviewing plus nicotine patch (n = 22). Groups did not differ at 3 months on biochemically-verified abstinence. The sample reduced cigarettes per day by half a pack and the percent of smoking days by 41%, and 22% were abstinent at 3-month follow-up. Compliance with the nicotine patch was poor and declined over time, but patch use was unrelated to carbon monoxide level at 3-month follow-up. Smoking cessation interventions for people with HIV can be helpful and should include components that encourage some smoke-free days, increase self-efficacy, and attend to adherence to nicotine replacement treatment.

show abstract

Section: Discussionmentioning

confidence: 89%

A Test of Motivational Plus Nicotine Replacement Interventions for HIV Positive Smokers

2007

View full text Add to dashboard Cite

show abstract

“…Additionally, many investigations have shown a relationship between nicotine patch adherence and smoking cessation treatment outcome (Alterman et al, 1999;Cooper et al, 2004;Jolicoeur et al, 2000), and one study showed that advice from health care providers was related to adherence to the nicotine patch (Orleans et al, 1994). Although adherence has been examined in nicotine patch treatment, no studies to date have explored assessment tools to evaluate this important construct.…”

Section: Adherence To Nicotine Patch Treatment For Smoking Cessationmentioning

confidence: 99%

Factor structure and validity of the Medication Adherence Questionnaire (MAQ) with cigarette smokers trying to quit

Toll

McKee

Martin

et al. 2007

Nicotine & Tobacco Res.

View full text Add to dashboard Cite

The Medication Adherence Questionnaire (MAQ) is a scale used to evaluate adherence to medications. The present study assessed the factor structure and validity of the MAQ with cigarette smokers. A principal components analysis was conducted on MAQ scores from a sample of smokers presenting for treatment in a clinical trial of naltrexone and nicotine patch for smoking cessation (N=385). Indices of convergent and predictive validity were tested using electronic medication caps for naltrexone, nicotine patch counts, plasma drug levels of naltrexone, and treatment outcomes. The principal components analysis revealed two factors. Factor 1, labeled "unintentional nonadherence," measured the extent to which individuals were nonadherent because they were careless or forgot to take their medications. Factor 2, labeled "purposeful nonadherence," assessed nonadherence related to purposefully stopping medication use after feeling better or worse. Only the second factor was shown to have good convergent and predictive validity. Specifically, this factor was related to pilltaking behavior measured with electronic medication caps and drug plasma levels and nicotine patch use based on nicotine patch count data, and it was associated with smoking cessation outcome. Thus the purposeful nonadherence factor of the MAQ may be used as a brief screening tool for medication adherence with cigarette smokers seeking treatment. Information obtained with this questionnaire could be used to counsel patients regarding the importance of medication adherence.

show abstract

“…Several studies have demonstrated that cognitive factors such as motivation and self-efficacy predict adherence to pharmacotherapies for smoking cessation and/or to behavioral interventions for addictions (Alterman, Gariti, Cook, & Cnaan, 1999;Joe, Simpson, & Broome, 1999;Simpson & Joe, 2004). In addition, greater adherence to transdermal nicotine replacement has been linked to better treatment outcomes in smoking cessation studies (Cooper et al, 2004;Shiffman, Sweeney, Ferguson, Sembower, & Gitchell, 2008), and there is strong evidence for a relationship between adherence to behavioral treatments and substance-abuse outcomes in general (Simpson & Joe, 2004). To our knowledge, however, the extent to which adherence to pharmacotherapy and counseling mediate the relationship between self-efficacy in quitting, perceived difficulty in quitting, or motivation to quit and successful smoking cessation has not yet been examined.…”

Section: Introductionmentioning

confidence: 99%

Preliminary Evidence That Adherence to Counseling Mediates the Effects of Pretreatment Self-efficacy and Motivation on Outcome of a Cessation Attempt in Smokers with ADHD

Heffner

Lewis

Winhusen

2012

Nicotine & Tobacco Research

View full text Add to dashboard Cite

Background: Few studies have evaluated predictors of smoking cessation outcomes in smokers with attention-deficit/hyperactivity disorder (ADHD), which could help to improve suboptimal treatment outcomes in this population. The purpose of this study was to examine pretreatment thoughts about smoking abstinence (i.e., desire to quit, perceived difficulty quitting, and expected success in quitting) as predictors of smoking cessation outcomes in smokers with ADHD and to determine the extent to which treatment adherence mediates these relationships.

show abstract

Correlates of adherence with transdermal nicotine

Cited by 36 publications

References 20 publications

A Test of Motivational Plus Nicotine Replacement Interventions for HIV Positive Smokers

A Test of Motivational Plus Nicotine Replacement Interventions for HIV Positive Smokers

Factor structure and validity of the Medication Adherence Questionnaire (MAQ) with cigarette smokers trying to quit

Preliminary Evidence That Adherence to Counseling Mediates the Effects of Pretreatment Self-efficacy and Motivation on Outcome of a Cessation Attempt in Smokers with ADHD

Contact Info

Product

Resources

About